Press release
-
Press Release
Riyadh Action Agenda Gathers Steam as Land Governance Takes Center Stage at UNCCD COP16
RIYADH, Saudi Arabia, Dec. 8, 2024 /PRNewswire/ — The role of governance in local, regional and international efforts to tackle…
Read More » -
Press Release
Blueprint Medicines’ Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
— ASH data reinforce survival benefits of front-line AYVAKIT® (avapritinib) use in patients with advanced SM — — Bone density…
Read More » -
Press Release
Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting
73% of the NKTR-255 treatment group compared to 50% of the placebo group achieved a complete response at 6 months…
Read More » -
Press Release
Researchers Report New Opportunities to Improve Quality of Life for People with Non-Malignant Blood Disorders
Studies show promising new options to address unmet needs in sickle cell disease and immune thrombocytopenia SAN DIEGO, Dec. 7,…
Read More » -
Press Release
Blokees’ Figures from Multiple IPs Amaze Fans at 2024 Singapore Comic Con
SHANGHAI, Dec. 7, 2024 /PRNewswire/ — During the two-day 2024 Singapore Comic Con (December 7–8), Blokees unveiled its new Sesame Street…
Read More » -
Press Release
BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Phase 3 Study Results Demonstrated Three Year, Disease-Free Survival of 96% THOUSAND OAKS, Calif., Dec. 7, 2024 /PRNewswire/ — Amgen…
Read More »
